Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2000
10/25/2000CN1057697C Powder for curing ulcerative colitis and proctitis ulcerosa and its preparing method
10/25/2000CN1057696C Chinese drug composition for curing gastritis
10/25/2000CN1057693C Hepatitis B virus converting negative tablet
10/25/2000CN1057681C Lithagogue medicine composition
10/25/2000CN1057680C Traditional Chinese medicine for curing dysentery
10/25/2000CN1057677C Ready made Chinese medicine for treatment of acute and chronic gastritic and peptic ulcer
10/24/2000US6136974 Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments
10/24/2000US6136861 Bicyclo[2.2.1]heptanes and related compounds
10/24/2000US6136859 Mixture of selenmethionine, carotene, ascorbic acid, tocopherol, methionine and coenzyme q10 in a carrier
10/24/2000US6136848 Antiallergens; asthma therapy
10/24/2000US6136839 Using a sulfone or sulfoamide benzene compound
10/24/2000US6136596 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
10/24/2000US6136344 Oral pharmaceutical dosage form
10/24/2000CA2220873C Method for reproducing in vitro the rna-dependent rna polymerase and terminal nucleotidyl transferase activities encoded by hepatitis c virus (hcv)
10/24/2000CA2157247C Physical form of dihydro-2,3-benzodiazepine derivative
10/24/2000CA2137445C Naphtalene derivates, process for their preparation and pharmaceutical compositions containing them
10/19/2000WO2000061788A2 Poly(dipeptide) as a drug carrier
10/19/2000WO2000061774A2 Bone morphogenic proteins
10/19/2000WO2000061762A1 RECOMBINANT TOXIN A/TOXIN B VACCINE AGAINST $i(CLOSTRIDIUM DIFFICILE)
10/19/2000WO2000061755A2 Secreted human proteins
10/19/2000WO2000061750A2 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS
10/19/2000WO2000061748A1 48 human secreted proteins
10/19/2000WO2000061620A1 49 human secreted proteins
10/19/2000WO2000061608A2 Low-molecular inhibitors of complement proteases
10/19/2000WO2000061606A1 Novel human voltage-gated potassium channel
10/19/2000WO2000061604A2 Pharmaceutical compounds
10/19/2000WO2000061596A1 50 human secreted proteins
10/19/2000WO2000061587A1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
10/19/2000WO2000061583A1 Xanthine derivatives and analogs as cell signaling inhibitors
10/19/2000WO2000061554A1 1-amino ethylindole derivatives for the treatment of urinary incontinence
10/19/2000WO2000061553A1 2-aminoethyl-indole derivatives, their preparation and therapeutic use
10/19/2000WO2000061542A1 Caspase inhibitors and the use thereof
10/19/2000WO2000061541A2 Pharmaceutical compounds
10/19/2000WO2000061539A1 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors
10/19/2000WO2000061191A2 Heat stable coated colloidal iron oxides
10/19/2000WO2000061161A2 A pharmaceutical formulation useful for the treatment of hepatitis b, hepatitis c and other viral infections of the liver and a process for its preparation
10/19/2000WO2000061160A2 A pharmaceutical formulation useful for the treatment of hepatitis b hepatitis c and other viral infections of the liver and a pr ocess for its preparation
10/19/2000WO2000061150A1 Antisense modulation of fas mediated signaling
10/19/2000WO2000061118A1 Anhydrous tablet of ranitidine hydrochloride with double-layer coating and its composition
10/19/2000WO2000042992A3 Compositions and methods for mucosal delivery
10/19/2000WO2000041505A3 Anthranilic acid derivatives
10/19/2000WO2000034485A3 Beta-1,3-galactosyltransferase homologs
10/19/2000WO2000012720A8 Elongase genes and uses thereof
10/19/2000DE19917930A1 Treating estrogen deficiency associated disorders, e.g. menopausal problems, osteoporosis, neoplasia or neurodegenerative disease, using new or known ent-steroids having bone-selective estrogenic activity
10/19/2000DE19915602A1 3-Amino-4-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung 3-amino-4-arylpropan-1-ol-derivatives, their preparation and use
10/19/2000DE19915601A1 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung 3-amino-3-arylpropan-1-ol-derivatives, their preparation and use
10/19/2000CA2371172A1 50 human secreted proteins
10/19/2000CA2370767A1 49 human secreted proteins
10/19/2000CA2370425A1 Pharmaceutical compounds
10/19/2000CA2369981A1 Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same
10/19/2000CA2369822A1 Novel human voltage-gated potassium channel
10/19/2000CA2369619A1 Caspase inhibitors and the use thereof
10/19/2000CA2369378A1 Low-molecular inhibitors of complement proteases
10/19/2000CA2369029A1 Poly(dipeptide) as a drug carrier
10/19/2000CA2368840A1 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors
10/19/2000CA2365917A1 Bone morphogenic proteins
10/19/2000CA2365915A1 Recombinant toxin a/toxin b vaccine against clostridium difficile
10/19/2000CA2365905A1 48 human secreted proteins
10/19/2000CA2365623A1 Tyrosine kinase substrate (tks) proteins
10/19/2000CA2334754A1 A pharmaceutical formulation useful for the treatment of hepatitis b, hepatitis c and other viral infections of the liver and a process for its preparation
10/18/2000EP1044215A1 Anti-inflammatory phenylalanine derivatives
10/18/2000EP1044210A1 Human dendriac and brainiac-3
10/18/2000EP1044189A1 Aryl fused azapolycyclic compounds
10/18/2000EP1044024A1 Use of pigmented retinal epithelial cells for creation of an immune privilege site
10/18/2000EP1044009A2 Methods and compositions employing red rice fermentation products
10/18/2000EP1044007A1 The use of mannose for combating protein loss enteropathy
10/18/2000EP1043998A1 USE OF PYRAZOLO 3,4-b] PYRIDINE AS CYCLIN DEPENDENT KINASE INHIBITORS
10/18/2000EP1043995A1 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
10/18/2000EP1043977A1 Oral pharmaceutical pulsed release dosage form
10/18/2000EP1043976A1 Oral pharmaceutical extended release dosage form
10/18/2000CN1270592A Spiroazabicyclic heterocyclic compounds
10/18/2000CN1270517A Antimicrobials
10/18/2000CN1270163A 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof
10/18/2000CN1270162A 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof
10/18/2000CN1270061A 弯曲菌疫苗 Campylobacter vaccine
10/18/2000CN1270051A Full-of-sap prescription
10/18/2000CN1270039A Chewing tablets of pilose antler, deerhorn and deer bone and preparing process thereof
10/18/2000CN1270027A Stable aqueous solution of phthalylglutamic acidimide derivative
10/18/2000CN1057464C Powder for treating cholecystitis and preparing method thereof
10/18/2000CN1057447C Quick-acting antidiarrhea oral liquor for infant and preparation method thereof
10/17/2000US6133479 Phenylethylamine derivatives, processes for preparing them and their use as pharmaceutical compositions
10/17/2000US6133319 For treating an interleukin-8 (il-8) mediated disease by administering a phenyl urea or phenyl thiourea of given formula, such as n-cyclohexyl-n'-(2-hydroxy-4-nitrophenyl)urea
10/17/2000US6133315 Administering to treat pancreatitis, thrombosis, ischemia, stroke, restenosis, emphysema or inflammation in a mammal; compounds such as 2-chlorobenzenesulfonic acid 3-(3-amidinopropoxy)-5-methylphenyl ester hydrochloride
10/17/2000US6133311 Method for preventing or treating elevated blood lipid level-related diseases by administering natural phenolic compounds
10/17/2000US6133277 Little or no vasoconstrictor activity; gastrointestinal disorders, e.g. dyspepsia, early satiety, bloating and anorexia; 1-(3-((3,4-dihydro-2h-1-benzopyran-2-yl)methyl)-amino)-propyl)-tetrahydro -2(1h)-primidinone
10/17/2000US6133272 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
10/17/2000US6133260 Use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of Helicobacter pylori infections and associated gastroduodenal diseases
10/17/2000US6133257 Fused polycyclic 2-aminopyrimidine derivatives
10/17/2000US6133240 Tetrahydronapthalene derivatives and their therapeutic use
10/17/2000US6132966 Enzymatic nucleic acid which specifically prevents viral replication; for the treatment of transformed hepatocytes and suppression of viral infection humans, animals and primates
10/17/2000US6132771 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent
10/17/2000US6131226 1,4-dihydropyridine compounds as bradykinin antagonists
10/17/2000CA2178752C N-terminally chemically modified protein compositions and methods
10/17/2000CA2156726C Bisacodyl dosage form
10/12/2000WO2000060094A1 Modified lactococci expressing a catalase and their uses
10/12/2000WO2000060082A2 Vesicle associated proteins
10/12/2000WO2000060080A2 Molecules of the immune system
10/12/2000WO2000059946A1 Hydroxymatairesinol in cancer prevention
10/12/2000WO2000059941A1 Purposeful movement of human migratory cells away from an agent source
10/12/2000WO2000059929A1 Macrocyclic peptides active against the hepatitis c virus
1 ... 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 ... 1258